1 -ATPase (V-ATPase) is a large, multisubunit membrane protein complex responsible for the acidification of subcellular compartments and the extracellular space. VATPase activity is regulated by reversible disassembly, resulting in cytosolic V 1 -ATPase and membrane-integral V 0 proton channel sectors. Reversible disassembly is accompanied by transient interaction with cellular factors and assembly chaperones. Quantifying protein-protein interactions involving membrane proteins, however, is challenging. Here we present a novel method to determine kinetic constants of membrane protein-protein interactions using biolayer interferometry (BLI). Yeast vacuoles are solubilized, vacuolar proteins are reconstituted into lipid nanodiscs with native vacuolar lipids and biotinylated membrane scaffold protein (MSP) followed by affinity purification of nanodisc-reconstituted V-ATPase (V 1 V 0 ND). We show that V 1 V 0 ND can be immobilized on streptavidin-coated BLI sensors to quantitate binding of a pathogen derived inhibitor and to measure the kinetics of nucleotide dependent enzyme dissociation.
Introduction
The vacuolar H 1 -ATPase (V-ATPase; V 1 V 0 -ATPase) is an ATP-dependent proton pump present in all eukaryotic cells. The enzyme is typically localized to the endomembrane system and functions in acidifying organelles for essential cellular functions including pH homeostasis, membrane trafficking, endocytosis, hormone secretion, and lysosomal degradation. 1 In certain specialized cell types such as osteoclasts, renal tubular cells and cells of the male reproductive tract, the V-ATPase is found on the plasma membrane where it acidifies the extracellular environment.
Complete loss of V-ATPase activity is embryonic lethal in mammals, 2, 3 highlighting the essential nature of the enzyme. Not surprisingly therefore, aberrant V-ATPase displaying hyper-or hypo-activity has been implicated in a number of widespread human diseases such as osteoporosis, 4 renal tubular acidosis, 5 deafness, 6 male infertility, 7 viral infection, 8 diabetes, 9 and cancer, 10 and it has been suggested that V-ATPase may represent a valuable drug target for the development of therapies against these diseases.
11,12
V-ATPase is a membrane integral, multi-subunit protein complex composed of a cytosolic ATP hydrolyzing sector, V 1 , and a membrane-integral ion translocating sector, V 0 (Fig. 1 ). V-ATPase is highly conserved from yeast to human and thanks to the relative ease of genetic manipulation, yeast has been a powerful model system to study the structure and mechanism of the eukaryotic enzyme. In yeast, V 1 is composed of subunits A 3 B 3 (C)DE 3 FG 3 H 13 and V 0 contains subunits a,c 8 ,c 0 ,c 00 ,d,e,f. 14, 15 V-ATPase belongs to the family of rotary motor enzymes that also includes F-and A-ATPase/synthase found in bacteria, mitochondria, chloroplasts and Archaea. ATP hydrolysis in V 1 is coupled to rotation of a membrane integral ring of c subunits ("proteolipid" ring, composed of c 8 ,c 0 ,c 00 ) in V 0 , which results in an uphill transport of protons across the membrane. 16 However, unlike F-and A-type motors, V-ATPase is regulated in vivo by a unique mechanism referred to as "reversible disassembly", a process first described in yeast 17 and insect. 18 Upon nutrient deprivation in yeast, for example, V 1 disengages from V 0 with concomitant silencing of the enzyme's ATPase and proton translocation activities. Reversible enzyme dissociation is conserved in higher organisms [19] [20] [21] [22] [23] and it has been proposed that the process provides a unique opportunity for therapeutic intervention by allowing for modulation of V-ATPase activity (rather than complete inhibition) in a tissue specific manner. 24 Reversible disassembly has been extensively studied in yeast 25 and insect 26 and it is known that the process requires an ATP hydrolysis competent enzyme 25, 27 in addition to transient interaction with cellular effectors 28 and chaperones. 29 Understanding these interactions and their role in reversible disassembly would greatly benefit from a controlled in vitro system employing purified components. However, the limited stability of detergent solubilized VATPase and the difficulties with analyzing proteinprotein interactions in presence of detergent have limited such studies thus far.
Here we have developed a method for reconstituting V-ATPase into lipid nanodiscs using native vacuolar lipids and membrane scaffold protein (MSP) engineered to contain an N-terminal biotin acceptor protein (BAP) tag for biotinylation in E. coli. We show that lipid nanodisc-reconstituted V 1 V 0 (V 1 V 0 ND) is highly active and that the preparation can be immobilized on streptavidin-coated biosensors for binding studies using biolayer interferometry (BLI). We further demonstrate that the system can be used to study the kinetics of the interaction between V-ATPase and cellular factors known to bind to the enzyme and for monitoring the nucleotide-dependent dissociation of the complex in real time. 
Results

Preparation and characterization of lipid nanodisc-reconstituted V-ATPase
We initially attempted to first affinity purify VATPase followed by nanodisc reconstitution using E. coli polar lipids as described for P-glycoprotein. 30 However, the tendency of the detergent solubilized enzyme to dissociate precluded this approach. We therefore developed a procedure that minimizes prolonged detergent exposure and allows for retention of native vacuolar lipids, some of which have been shown to be essential for enzyme function. 31 To that end, total vacuolar proteins are detergent solubilized, reconstituted into nanodiscs with native vacuolar lipids (without the addition of exogenous lipids) followed by affinity purification of nanodiscreconstituted V 1 V 0 (V 1 V 0 ND) (Fig. 1) . The resulting V 1 V 0 ND preparation is highly purified, showing bands for all the V-ATPase subunits that can be resolved on SDS-PAGE gels as seen in earlier preparations of detergent solubilized enzyme 32 besides a band for MSP [ Fig. 2(A) ]. V 1 V 0 ND displays robust MgATPase activity of 7.3 6 0.3 U/mg (three independent purifications), 98% of which is inhibited by Concanamycin A [ Fig. 2(B) , red trace]. Concanamycin A (ConA) is a specific inhibitor of the V-ATPase that binds to V 0 and inhibits rotation of the proteolipid ring, in turn inhibiting ATPase activity in the coupled V 1 . 33 The specific activity of purified vacuoles was 2.9 6 0.9 U/mg (nine independent purifications), consistent with previously published results. 34 Upon solubilization of vacuoles with dodecyl maltoside (DDM), the specific activity remained unchanged. However, while 85% of the ATPase activity of vacuoles was inhibited by ConA [ Fig. 2(B) , purple trace], inhibition of detergent-solubilized enzyme was only 58% [ Fig. 2 (B), blue trace], suggesting that detergent causes partial uncoupling of the enzyme as has been described for the related F-ATPase. 35 Therefore, the virtually complete inhibition of V 1 V 0 ND's ATPase activity by ConA indicates tight coupling of ATPase and proton pumping activities in lipid nanodisc-reconstituted V 1 V 0 . To verify the structural integrity of purified V 1 V 0 ND, the preparation was subjected to glycerol gradient centrifugation followed by negative stain electron microscopy (EM). As can be seen from the silver stained SDS-PAGE gel of the glycerol gradient fractions, the majority of the preparation migrated in a single peak on the gradient with only trace amounts of free subunits in fractions near the top of the gradient [ Fig . Taken together, reconstitution of V-ATPase into lipid nanodiscs using native vacuolar lipids allows purification of a stable, highly active, and monodisperse enzyme preparation suitable for structural and biophysical studies.
Biolayer interferometry of V 1 V 0 ND for analysis of protein binding
The MSP used for reconstitution of the V-ATPase into lipid nanodiscs contained an engineered Nterminal BAP tag for specific attachment of a single biotin during protein expression in E. coli ( Fig. 1) . Initial experiments revealed that the level of biotinylation of MSP was close to stoichiometric (Supporting Information Fig. S1 ), that the biotin tag in V 1 V 0 ND was accessible for binding to streptavidincoated BLI sensors, and that a concentration of 5 mg/mL V 1 V 0 ND produced sufficient BLI signal for subsequent binding or dissociation experiments (data not shown). As a proof-of-principle, we then tested binding of the well characterized V-ATPase inhibitor SidK to immobilized V 1 V 0 ND for determining kinetic constants of the interaction (Fig. 3 ). SidK is a 60 kDa soluble polypeptide expressed by the pathogenic organism Legionella pneumophilia that specifically targets host cell V-ATPases to inhibit phagosome acidification and subsequent digestion of the bacterium. It was previously shown that SidK inhibits yeast V-ATPase by binding to the catalytic A subunit of the complex. 36 BLI sensors with immobilized V 1 V 0 ND were dipped in wells containing different concentrations of purified GST-tagged SidK. The SidK-V 1 V 0 ND interaction exhibited concentration dependence and the association and dissociation rates were used to estimate a K d of the interaction of 3.5 nM (Fig. 3) . In another experiment, we tested binding of a monoclonal antibody directed against the catalytic A subunit of the enzyme and fitting of the binding data revealed a tight interaction in the sub-nM range (Supporting Information Fig. S2 ). In summary, the binding experiments described above demonstrate that V-ATPase reconstituted into nanodiscs using native lipids and biotinylated MSP can be used for BLI to study the kinetics of inhibitor and antibody binding.
Dissociation of V 1 from V 0 monitored by biolayer interferometry
As mentioned earlier, under conditions of starvation, V 1 dissociates from V 0 , causing silencing of the enzymes ATPase and proton translocation activities. We used immobilized V 1 V 0 ND for BLI as an experimental setup to understand the kinetics of the dissociation of V 1 from V 0 . From experiments with yeast vacuoles, it is known that V 1 can be released from membrane integral V 0 by treatment with chaotropic agents such as KNO 3 or KI in presence of MgATP. 37, 38 To determine the rate of chaotropeinduced dissociation, BLI sensors with immobilized V 1 V 0 ND were dipped into wells containing KNO 3 with or without 1 mM MgATP (Fig. 4 ). Under these Biolayer interferometry with V 1 V 0 ND. 5 lg/mL of biotinylated V 1 V 0 ND was used to load streptavidin sensors (step 1) followed by dipping the sensors in buffer (step 2). The sensors were then dipped into wells containing either buffer, 30, 90, 270, or 600 nM of GST-tagged SidK to measure association rates (step 3). All the sensors were then dipped into buffer containing wells to measure dissociation rates (step 4). GST-SidK showed concentration dependent interaction with V 1 V 0 ND as evident from the association and dissociation phases (enlarged box). The signal obtained in buffer (red) was subtracted from the GST-SidK signal and the resultant curves were globally fit to a one site binding equation (black dotted traces). The on rate was found to be 1. conditions, the BLI signal rapidly decreased but only when MgATP and the chaotrope were present together, consistent with the earlier experiments using yeast vacuoles. 37, 38 Upon chaotrope treatment in presence of MgATP, the BLI signal decreased by only 15%, an unexpected finding considering that the size of the V 1 sector (600 kDa) is comparable to the size of V 0 in nanodiscs (400 kDa without lipids). However, incomplete stripping of V 1 from V 0 had also been observed after chaotrope treatment of yeast vacuoles. 37, 38 It is also possible that the majority of the BLI signal was due to the nanodisc bound V 0 as the method of detection could be more sensitive to the nanodiscs bound close to the sensor surface. As a control, chaotrope treated sensors were dipped into wells containing Prescission protease. The close to complete loss of signal due to proteolytic cleavage of the protease site engineered between the BAP tag and the N-terminus of MSP [ Fig. 1(B) ] confirmed that the majority of the initial BLI signal was due to specific binding of V 1 V 0 ND via biotinylated MSP (Fig. 4) . Of course, chaotrope induced dissociation is not physiological and to estimate the propensity of the enzyme to dissociate under more native conditions, we tested the effect of nucleotides and known VATPase inhibitors on the dissociation of V 1 from V 0 (Fig. 5) (Fig. 5, pink trace) , MgATP with ConA (V 0 inhibitor) (Fig. 5, orange trace) , MgATP with Nethylmaleimide (NEM; V 1 inhibitor), which covalently modifies an essential cysteine in the P-loops of the catalytic A subunits, thereby preventing substrate binding to active sites 39 ( Fig. 5, red suggesting that destabilization of the V 1 /V 0 interface due to ATP hydrolysis is a conserved feature of the enzyme. Consistent with earlier findings that V- Figure 4 . Biolayer interferometry to monitor the dissociation of V 1 from V 0 in real time. 5 lg/mL of biotinylated V 1 V 0 ND was used to load the streptavidin sensors (step 1) followed by dipping the sensors in buffer (step 2). One sensor was dipped in 300 mM KNO 3 (green trace) while the other sensor was dipped in 300 mM KNO 3 with 1 mM MgATP (red trace) (step 3). In the presence of both KNO 3 and MgATP, V 1 was released from V 0 as indicated by a fast drop in BLI signal (red trace, step 3). The sensors were then dipped in buffer (step 4). The remaining V 1 V 0 ND and V 0 ND molecules on the sensors were then released by dipping the sensors in 0.2 U/ lL of Prescission protease (step 5). The experiment has been illustrated using schematics of V 1 V 0 ND and its components. Representative experiment from two repeats is shown. Figure 5 . Effect of nucleotides and inhibitors on the dissociation of V 1 from V 0 . V 1 V 0 ND immobilized on streptavidin sensors (step 1) was dipped into buffer (step 2), and then into wells containing either buffer, 1 mM MgATP, 1 mM MgAMPPNP, 2 mM NEM/1 mM MgATP, 0.2 lM Concanamycin A/1 mM MgATP, or 300 mM KNO 3 /1 mM MgATP (step 3) followed by buffer (step 4). Following dissociation of V 1 from V 0 in step 3, the remaining V 1 V 0 ND or V 0 ND was released from the sensors using 0.2 U/lL of Prescission protease (step 5). Inset: Enlarged view of the dissociation of V 1 from V 0 (step 3). In the presence of MgATP and MgATP/ConA (pink and orange traces, respectively), V 1 is released from V 0 at a slow rate. The two curves were fit to the equation for a single exponential decay (black dotted trace) and the off rates were found to be 1 3 10 23 6 3. . In the presence of buffer (green), MgAMPPNP (blue) and NEM/MgATP (red), V 1 remains associated with V 0 over the duration of the experiment. Representative experiment from two repeats is shown.
ATPase must be ATP hydrolysis-competent for in vivo dissociation to occur, 25, 40 we observed that inhibition of V 1 by MgAMPPNP or NEM prevented dissociation (Fig. 5) . Interestingly, release of V 1 from V 0 under conditions of ATP hydrolysis did not appear to be impaired in presence of ConA, an observation that seems inconsistent with the fact that V 1 V 0 ND's ATPase activity is close to zero in presence of the inhibitor [ Fig. 2(B) ]. Taken together, the results show that BLI of immobilized V 1 V 0 ND can be used to monitor the dissociation of the complex in real time and while the observed rate of dissociation is significantly lower than the rate observed in live yeast, 25 above experiments indicate that V 1 V 0 ND is disassembly competent during catalytic turnover.
Discussion
Biophysical characterization of membrane proteins and membrane protein-protein interaction is challenging due to the presence of detergents that are required for keeping membrane proteins water soluble. Detergents are known to destabilize multisubunit membrane protein complexes 35, 41 and the light scattering from detergent micelles can interfere with binding assays that depend on optical detection methods. The results summarized above indicate that there are two major advantages of using the "nanodisc-reconstitution before purification" strategy. First, the lipids used for the process of reconstitution were derived directly from yeast vacuoles and therefore represent the native environment of the enzyme, an important aspect as it has been shown that in vivo V-ATPase activity depends on low abundance, long chain fatty acid sphingolipids. 31 Second, V-ATPase is held together by multiple low-affinity protein-protein interactions for efficient enzyme regulation by reversible disassembly. 42 These lowaffinity interactions are susceptible to breakage when exposed to detergent for long periods of time. Multiple attempts were made to first extract and purify the V-ATPase from pelleted membranes followed by reconstitution into E. coli lipid-containing nanodiscs as described for the enzyme's V 0 membrane sector. 43 However, likely due to the prolonged exposure to detergent required for purifying the complex, the resultant preparation showed a significant fraction of disassembled V 1 and V 0 particles with little or no measurable ATPase activity (data not shown). Using the "nanodisc-reconstitution before purification" strategy to obtain V 1 V 0 ND, we found that the resulting preparation consisted of close to completely assembled V-ATPase with high specific ATPase activity. The ATPase activity was 98% inhibited by Concanamycin A, suggesting tight coupling between V 1 V 0 ND's V 1 and V 0 sectors. For immobilization on streptavidin-coated BLI sensors, we engineered a BAP tag at the N-terminus of MSP for site directed biotinylation during expression in E. coli. The high affinity of the streptavidinbiotin interaction allows immobilization of V 1 V 0 ND at a relatively low concentration with little risk of nonspecific binding. We first showed that our method can be used successfully to study the kinetics of interaction of the V-ATPase with binding partners such as an anti-subunit A monoclonal antibody and the pathogen derived inhibitor, SidK. Both examples allowed an estimate of the K d s of the interactions ranging from the sub-nM (anti-A mAb) to the low nM (SidK) range. In addition, we showed that the dissociation of V 1 from V 0 under different conditions could be monitored in real time. The data indicate that ATP hydrolysis is required for disassembly to occur, consistent with in vivo and in vitro experiments conducted with yeast cells 25 and detergent solubilized insect V-ATPase, 27 respectively. However, the observation that the V 0 specific inhibitor ConA did not prevent or slow down disassembly was surprising, but it is possible that residual turnover and/ or the conformational changes induced by rapid binding and release of MgATP are sufficient to destabilize the complex. It should be noted that the rate of V 1 V 0 disassembly upon glucose withdrawal in live yeast occurs within minutes and is therefore significantly faster than the rate observed here.
Thus, while the experiment shows that MgATP hydrolyzing V-ATPase has the propensity to dissociate, additional events induced by, for example, nutrient withdrawal are required to accelerate the process. The experimental setup developed here will allow for a systematic analysis of the cellular factors that may be involved in promoting or impeding the disassembly process in vivo such as phosphorylation, 26 variations in pH 44 and the interaction with mTORC, 22 phosphoinositides 45 or glycolytic enzymes. 28 
Conclusion and Future Perspective
We have developed a procedure to reconstitute yeast V-ATPase into native lipid containing nanodiscs for binding and dissociation assays using biolayer interferometry. Recent progress with the structure determination of the assembled V-ATPase 15 along with those of the disassembled and silenced V 1 46 and V 0 43,47 suggest that following disassembly, there is a mismatch in the subunit conformations between V 1 and V 0 that may act to prevent spontaneous reassembly under conditions when enzyme activity is not desired. 43, 46 To overcome the kinetic barriers for reassembly created by the conformational mismatch, subunit rearrangements at the V 1 /V 0 interface facilitated by effector and chaperone proteins such as the RAVE complex 48 are required. The here developed tool of immobilizing V 1 V 0 ND for BLI can be used to study the function of these effector and chaperone proteins in the (re)assembly process. The method can also be extended to the discovery of small molecules that will modulate enzyme assembly, a strategy that may ultimately lead to the development of therapies designed to overcome aberrant VATPase activity in human disease.
Materials and Methods
Materials
The plasmid encoding 6XHis-tagged membrane scaffold protein, pMSP1E3D1, was a gift from Dr. Stephen Sligar (Addgene plasmid # 20066). 49 Molecular biology reagents were purchased from Takara Bio Inc. Zymolyase 100T was from amsbio. An Nterminal extension of MSP encoding the 7XHis tag, BAP tag and Prescission protease cleavage site was synthesized and subcloned into the pET28a vector (pMSP1E3D1) by Bio Basic Inc., resulting in plasmid pHBPMSP1E3D1. All other reagents were of analytical grade.
Strains
A yeast strain deleted for the VMA10 gene (subunit G), BY4741 vma10D:: KanMX was a kind gift from Dr. Patricia Kane, SUNY Upstate Medical University. The 3 0 and 5 0 UTR regions of VMA10 along with the KanMX selection marker was amplified from genomic DNA using the following primers: Vma10-delKanfwd: 5 0 gcc aca ccc ttc cct att aac tgg act cc tat tcc agc tca tc 3 0 and Vma10delKanrev: 5 0 ggc tga atg gat aaa gcg aga gtc gta aag acc gaa tgc aat gtc 3 0 . The PCR product was gel purified and transformed into a wild-type yeast strain SF838-5Aa 50 for homologous recombination. Transformants were selected based on their resistance to G418 and their inability to grow on pH 7.5 and Ca 21 . Deletion of the VMA10 gene was confirmed by DNA sequencing. For affinity purification of V 1 V 0 ND, SF838-5Aa vma10D::KanMX was transformed with a pRS315 plasmid encoding the G subunit with an N-terminal FLAG-tag. 51 
Purification of biotinylated MSP
A plasmid encoding the BirA gene for in vivo biotinylation of the BAP tag (pBirAcm 52 ) was a kind gift from Dr. Thomas Duncan, SUNY Upstate Medical University. E. coli strain BL21 (DE3) was cotransformed with pHBPMSP1E3D1 and pBirAcm. Cells were grown in rich broth supplemented with 0.1 mM D-biotin, 34 mg/mL chloramphenicol and 30 mg/mL kanamycin at 378C to an OD 595 of 0.5 followed by induction with 0.5 mM IPTG at 378C for 3-4 h. Biotinylated MSP was purified as described. 43 The extent of biotinylation of MSP was estimated by performing pull down assays with streptactin beads as follows. MSP eluted from the Ni column was diluted 1:2 and 1:3 in streptactin buffer (15 mM Tris, pH 7.8, 150 mM NaCl, 0.5 mM EDTA) and incubated with 100 mL streptactin beads at 48C for 1 h. The beads were washed for 1 h at 48C in streptactin buffer, boiled in cracking buffer for 10 min and the beads, supernatant and wash were resolved using SDS-PAGE. 100 mL of streptactin buffer served as a control.
Isolation of vacuoles
Vacuoles were isolated by flotation on Ficoll density gradients as described with the following modifications. 53 Briefly, yeast strain SF838-5Aa vma10D transformed with pRS315 encoding FLAG tagged G subunit 51 was grown to an OD 595 of 1.0 in YPD, pH 5 media and harvested by centrifugation at 5,0003g for 30 min. Cells from 12 l of culture were washed and resuspended in 100 mL of 1.2M sorbitol supplemented with 15 mg of zymolyase. Spheroplasts were recovered in 100 mL of 23 YPD and 100 mL of 2.4M sorbitol followed by resuspension in buffer A (10 mM MES-Tris pH 6.9, 0.1 mM MgCl 2 , and 12% Ficoll 400) supplemented with 1 mM PMSF and 2 mg/mL each of leupeptin, pepstatin, and chymostatin. The suspension was homogenized in a Dounce homogenizer using ten strokes and centrifuged for 40 min at 71,0003g. Vacuole wafers on top of the gradient were resuspended in buffer B containing 8% Ficoll 400, homogenized and centrifuged for 40 min at 71,0003g. Wafers were collected and resuspended in 1.5 mM Mes-Tris, pH 7.0, 4.8% glycerol, 1 mM BME. Vacuoles were analyzed for Concanamycin A sensitive ATPase activity using an ATP regenerating assay 46 and protein concentration was determined with a modified BCA assay. 54 Vacuoles were frozen in liquid nitrogen until further use.
Extraction of V-ATPase and reconstitution into lipid nanodiscs
Typically three batches of vacuoles (12 liters each) were thawed, combined and supplemented with 1 mM PMSF and 2 mg/mL each of leupeptin, pepstatin, and chymostatin. 1.2 mg of n-dodecyl b-D-maltopyranoside (DDM) per 1 mg of vacuolar membrane protein was added to the vacuoles and the mixture was rotated for 1 h at 48C. Detergent solubilized vacuoles were centrifuged at 100,0003g for 15 min. The pellet was discarded and the supernatant was used for reconstitution into lipid nanodiscs. To the detergent solubilized vacuole sample containing vacuolar lipids, purified biotinylated MSP was added in a molar ratio of 1:50 (vacuolar protein: biotinylated MSP) and the mixture was rotated at 48C for 1 h followed by the addition of 1.5 g of activated bio-beads and rotation of the sample at 48C for 2 h to remove detergent. V-ATPase containing lipid nanodiscs were then separated by anti-FLAG affinity chromatography (Fig. 1) . The FLAG column eluate was concentrated using a Vivaspin concentrator (100,000 MWCO) and subjected to a 50-20% glycerol gradient density centrifugation as described. 53 400 lL fractions were collected from top to bottom and analyzed by SDS-PAGE. For negative stain electron microscopy, 5 lL of V 1 V 0 ND (1:10 diluted from fraction 9 of the density gradient) was applied to glow-discharged carbon-coated copper grids and stained with 1% uranyl formate. Micrographs were collected on a JEOL JEM-2100 at a magnification of 60,0003 and a defocus of 21.5 lm.
Purification of GST-SidK
The plasmid for overexpression of GST-tagged SidK (pzl797) was a kind gift from Zhao-Qing Luo, Purdue University. 36 E. coli Rosetta2 cells (Novagen) were transformed with pzl797 and the cells were grown in rich broth supplemented with 34 lg/mL Ampicillin and 34 mg/mL Chloramphenicol. Cells were induced with 0.5 mM IPTG at an OD 595 of 0.5 and grown for 6 h at 258C. Cells were pelleted by centrifugation at 30003g, resuspended in GST buffer (10 mM Tris pH 7.8, 150 mM NaCl, 0.5 mM EDTA, 1 mM DTT) and stored at 2208C until use. Cells were lysed by sonication in the presence of 20 mg/mL DNase, 1 mg/ mL lysozyme and 1 mM PMSF. Lysed cells were centrifuged at 13,0003g for 40 min and the supernatant was subjected to affinity chromatography using a pre-equilibrated GST column. The column was washed with ten column volumes of GST buffer and eluted in ten 2 mL fractions using 10 mM reduced glutathione. To improve purity, eluted GST-SidK was subjected to size exclusion chromatography using a Superdex 200 1.6 cm 3 50 cm column attached to an € Akta FPLC (GE Healthcare). The peak fractions were pooled, analyzed by SDS-PAGE and used for biolayer interferometry.
Biolayer interferometry
An Octet-RED system with streptavidin-coated sensors (Fort eBio, SA biosensors, catalog number 18-5019) were used for biolayer interferometry, a technique similar to surface plasmon resonance. 55 In all BLI experiments described, the buffer used was 20 mM Tris, pH 7.4 with 150 mM NaCl, 0.5 mM EDTA, 1 mM b mercaptoethanol and 0.5 mg/mL BSA. All steps were conducted at 228C with each biosensor stirred in 0.2 mL of sample at 1000 rpm and a standard measurement rate of 5 s
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. In each case, the biosensors were pre-wetted in BLI buffer for 10 min and then dipped in wells containing 5 lg/ mL V 1 V 0 ND. Control experiments were performed to show that the buffer components did not interact with the streptavidin sensors. Details of individual BLI experiments are given in their respective figure legends. Fort eBio's data analysis software (version 6.4) was used for subtraction of reference sensors, Savitsky-Golay filtering and global or local fitting of the kinetic rates where applicable.
